Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Effect of ShenQi Compound Prescription on myocardial cell Bcl-2, Bax and NO of GK rats
Hits 1516  Download times 2149  Received:September 09, 2009  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2009.06.20
Key Words   Shenqi Compound Prescription;GK rats;diabetic mellitus;myocardial damage;myocardial apoptosis;experimental research;treatment of traditional Chinese medicine
Author NameAffiliation
KANG Jian 成都中医药大学附属医院肛肠科 成都 610075 
LIU Ya Chengdu University of TCM, Chendu 610075, China 
XIE Chun-guang 成都中医药大学附属医院 成都 610075 
殷丽平 Chengdu University of TCM, Chendu 610075, China 
Abstract
    [Objective] To research the effective mechanisms of ShenQi Compound Prescription having action on myocardial cell Bcl-2, Bax and NO in GK rats (Goto-Kakizaki wistar rats) of T2DM. [Methods] The DCM was induced in rats by i.p. injecting Nω-nitio-L-arginine methyl ester (L-NAME) and gavaging high fat diet. The GK rats (RBS≥11.1 mmol/L)were divided into four groups: model control group, ShenQi Compound Prescription high-dose group, ShenQi Compound Prescription low-dose group, control group, at the same time cure group treated by ShenQi Compound Prescription for four weeks to observe the common state, the levels of NO of myocardium, Bcl-2 and Bax proteinum expression.[Results] ShenQi Compound Prescription could ameliorate GK rats’ common state, increase NO of myocardium, increase the expression of Bcl-2 protein, inhibit the Bax protein expression, adjust Bax/Bcl-2 protein expression. [Conclusion] Diabetic myocardial damage was associated with NO, Bax and Bcl-2 protein. Shenqi Compound Prescription can increase NO level, increase the expression of Bcl-2 protein and inhibit the Bax protein expression of myocardium.

You are the 2306285 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.